The market performance of Mereo Biopharma Group Plc ADR’s stock has been harmonious in recent times. Over the last year, the company’s stock reached its highest point at $4.36 on 02/05/24, while the lowest value for the same duration was $0.69 on 03/29/23.
52-week price history of MREO Stock
Studying a stock’s 52-week price history, which includes both low and high prices, can help gauge its current status and potential future performance. Mereo Biopharma Group Plc ADR’s current trading price is -26.83% away from its 52-week high, while its distance from the 52-week low is 363.66%. The stock’s price range during the 52-week period has remained between $0.69 and $4.36. In the Healthcare sector, the company’s shares saw a trading volume of around 3.45 million for the day, which was evidently higher than the average daily volume of 1.65 million over the past three months.
Market Capitalization and Financial Performance: An In-Depth Look
Mereo Biopharma Group Plc ADR (MREO) has experienced a quarterly rise of 60.30% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 409.56M and boasts a workforce of 36 employees.
Making Sense of Trading Volume and Moving Average Data
Based on Barchart.com data, the company’s moving average over the 100-day period was 2.75, with a change in price of +1.26. Similarly, Mereo Biopharma Group Plc ADR recorded 1,421,689 in trading volume during the last 100 days, posting a change of +65.28%.
Examining MREO’s Debt-to-Equity Ratio: What You Need to Know
The debt-to-equity (D/E) ratio is a crucial measure that sheds light on a company’s financial health and market standing. It is determined by dividing a company’s overall liabilities by its shareholders’ equity, showing the extent of a company’s debt usage in financing its assets compared to the shareholders’ equity. At the time of writing, the total D/E ratio for MREO stands at 0.16. Similarly, the long-term debt-to-equity ratio is also 0.08.
MREO Stock Stochastic Average
As of today, Mereo Biopharma Group Plc ADR’s raw stochastic average for the last 50 days stands at 45.07%. This is a rise compared to the raw stochastic average of the previous 20 days, which was noted at 18.52%. Furthermore, the company’s Stochastic %K and %D values for the past 20 days were 15.99% and 18.32%, respectively.
MREO Stock Price Performance Analysis
Investors’ outlook regarding the stock price performance over the year has been split, with some feeling optimistic and others feeling pessimistic, as it’s been a mixed bag. Until today this year the stock’s price performance recorded an increase of 38.10%. However, over the last six months, the performance has been weaker by 127.86%. The price of MREO decreased -17.99% over the last 30 days. And in the last five days, it has fallen by -14.48%.
